Benzoxazepin oxazolidinone compounds and methods of use
US10112932B2 · kind B2 · utility
7Cited by
9References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2017 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Oct 10, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.